Thermo Fisher to sell three analytical divisions to GE Healthcare


Thermo Fisher Scientific has agreed to sell three of its analytical technology divisions to GE Healthcare for just over $1 billion (£645 million). The move is intended to satisfy the demands of US competition regulators and speed up final approval for Thermo’s ongoing takeover of Life Technologies.

GE will take over Thermo’s cell culture supplies, gene modulation and magnetic beads businesses, which are expected to generate combined sales in the region of $250 million for 2013.


Related Content

Business roundup

28 October 2009 Business

news image

Industry news, November 2009

Thermo Fisher to buy Life Technologies in $15.8bn deal

19 April 2013 Business

news image

Equipment suppliers unite, bringing Thermo into life sciences and sequencing markets

Most Read

Lawrencium experiment could shake up periodic table

9 April 2015 Research

news image

Measurement of first ionisation energy confirms electronic configuration but opens up an important debate

Silicon chip spots dangerous pathogens in human blood

10 April 2015 Research

news image

Silicon wafer doped with silver nanoparticles can rapidly identify E. coli in blood

Most Commented

Lawrencium experiment could shake up periodic table

9 April 2015 Research

news image

Measurement of first ionisation energy confirms electronic configuration but opens up an important debate

Big problems with little particles?

9 April 2015 Feature

news image

There is a risk that poor toxicology studies could start undermining the success of nanomaterials, reports Elinor Hughes